1. Home
  2. IPW vs LSTA Comparison

IPW vs LSTA Comparison

Compare IPW & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

N/A

Current Price

$1.27

Market Cap

1.1M

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$1.23

Market Cap

15.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IPW
LSTA
Founded
2018
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Misc Health and Biotechnology Services
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
15.9M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
IPW
LSTA
Price
$1.27
$1.23
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 980.9K
106.8K
Earning Date
11-24-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.42
EPS
N/A
★ N/A
Revenue
$19,956,938.00
★ $35,283,868.00
Revenue This Year
$596.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 56.90
52 Week Low
$0.18
$0.96
52 Week High
$1,836,562,600.00
$5.07

Technical Indicators

Market Signals
Indicator
IPW
LSTA
Relative Strength Index (RSI) 25.40 56.67
Support Level $0.18 $1.23
Resistance Level $1.57 $1.28
Average True Range (ATR) 0.36 0.12
MACD 14.78 0.04
Stochastic Oscillator 3.22 59.47

Price Performance

Historical Comparison
IPW
LSTA

About IPW iPower Inc.

iPower Inc is a technology-enabled commerce infrastructure company providing supply chain, logistics, fulfillment, warehousing and procurement solutions for e-commerce and distribution channels. Its product portfolio includes hydroponic products, gardening supplies, home goods and related accessories, with gardening and home products. Geographically, the company generates majority of its revenue from the United States, followed by Canada and other international markets.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: